Search research articles
Contact Us
Filters
Showing results (21-30 of 104) with videos related to
Page
of 11
Sort By:
British Journal of Clinical Pharmacology
|
September 1, 1987
A method for estimating the potency of angiotensin-converting enzyme inhibitors in man
A Wellstein, J Essig, G G Belz
The Journal of Biological Chemistry
|
August 19, 1994
Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth
F Czubayko, A T Riegel, A Wellstein
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1988
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots
A Wellstein, G G Belz, D Palm
European Journal of Clinical Pharmacology
|
January 1, 1988
Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol
P H Joubert, C P Venter, A Wellstein
Growth Factors (Chur, Switzerland)
|
June 1, 2000
Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the rat
A Aigner, C Malerczyk, R Houghtling, et al.
Endocrine-Related Cancer
|
October 6, 2000
Fibroblast growth factors, their receptors and signaling
C J Powers, S W McLeskey, A Wellstein
Polish Journal of Pharmacology and Pharmacy
|
March 1, 1984
Increase of Bmax-values of beta-adrenoceptor sites after chronic treatment with reserpine?
A Wellstein, B Jablonka, G Wiemer, et al.
The Journal of Biological Chemistry
|
August 1, 1997
Signal transduction pathways involved in the mitogenic activity of pleiotrophin. Implication of mitogen-activated protein kinase and phosphoinositide 3-kinase pathways
B Souttou, S Ahmad, A T Riegel, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
January 1, 1979
[Myocardial necrosis due to tocolysis with fenoterol (author's transl)]
K Meinen, H Breinl, E W Schmidt, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1978
Study to confirm the lack of severe cardiac side-effects following treatment with the beta-adrenergic drug fenoterol
K Meinen, H Breinl, E W Schmidt, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 104) with videos related to
Sort By:
Page
of 11
British Journal of Clinical Pharmacology
|
September 1, 1987
A method for estimating the potency of angiotensin-converting enzyme inhibitors in man
A Wellstein, J Essig, G G Belz
The Journal of Biological Chemistry
|
August 19, 1994
Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth
F Czubayko, A T Riegel, A Wellstein
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1988
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots
A Wellstein, G G Belz, D Palm
European Journal of Clinical Pharmacology
|
January 1, 1988
Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol
P H Joubert, C P Venter, A Wellstein
Growth Factors (Chur, Switzerland)
|
June 1, 2000
Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the rat
A Aigner, C Malerczyk, R Houghtling, et al.
Endocrine-Related Cancer
|
October 6, 2000
Fibroblast growth factors, their receptors and signaling
C J Powers, S W McLeskey, A Wellstein
Polish Journal of Pharmacology and Pharmacy
|
March 1, 1984
Increase of Bmax-values of beta-adrenoceptor sites after chronic treatment with reserpine?
A Wellstein, B Jablonka, G Wiemer, et al.
The Journal of Biological Chemistry
|
August 1, 1997
Signal transduction pathways involved in the mitogenic activity of pleiotrophin. Implication of mitogen-activated protein kinase and phosphoinositide 3-kinase pathways
B Souttou, S Ahmad, A T Riegel, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
January 1, 1979
[Myocardial necrosis due to tocolysis with fenoterol (author's transl)]
K Meinen, H Breinl, E W Schmidt, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1978
Study to confirm the lack of severe cardiac side-effects following treatment with the beta-adrenergic drug fenoterol
K Meinen, H Breinl, E W Schmidt, et al.
Page
of 11